Fibrobiologics Inc

FBLG10 Dec 2024
Healthcare
$2.47
-0.03 (-3.21%)
Lowest Today
$2.37
Highest Today
$2.55
Today’s Open
$2.47
Prev. Close
$2.49
52 Week High
$55
52 Week Low
$1.08
To Invest in Fibrobiologics Inc

Fibrobiologics Inc

Healthcare
FBLG10 Dec 2024
-0.03 (-3.21%)
1M
3M
6M
1Y
5Y
Low
$2.37
Day’s Range
High
$2.55
2.37
52 Week Low
$1.08
52-Week Range
52 Week High
$55
1.08
1 Day
-
1 Week
-1.35%
1 month return
-26.26%
3 month return
-34.7%
6 month return
-70.83%
1 Year return
-
3 Years return
-
5 Years return
-
10 Years return
-

Market Status

Fundamentals
Market Cap
86.3 mln
PB Ratio
31.53
PE Ratio
0
Enterprise Value
80.04 mln
Total Assets
11.82 mln
Volume

Company Financials

Fund house & investment objective

Company Information
FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. It holds 150+ U.S. and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer. FibroBiologics, Inc. was incorporated in 2021 and is based in Houston, Texas.
Organisation
Fibrobiologics Inc
Employees
10
Industry
Biotechnology
CEO
Mr. Peter  O'Heeron
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step